Cited by 1,126melanin and skin pigmentationParkinson's Disease Mechanisms and TreatmentsBioactive Compounds and Antitumor Agents

The DOI matches its Crossref record.

Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones

GRAHAM, DOYLE G.·1978·Molecular Pharmacology

DOI 10.1016/s0026-895x(25)13535-9

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0026-895x(25)13535-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 201–300 of 997

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
Micó, J. A., Rojas-Corrales, M. O., Gibert‐Rahola, J., Parellada, M., Moreno, D. M., Fraguas, D., Graell, M., Gil, J., Irazusta, J., Castro‐Fornieles, J., et al. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-26 · Cited by 114
Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Sayre, L. M. (1989) · Toxicology Letters · doi:10.1016/0378-4274(89)90168-9 · Cited by 115
Mechanisms of Dopamine-Induced Cell Death in Cultured Rat Forebrain Neurons: Interactions with and Differences from Glutamate-Induced Cell Death
Hoyt, K. R., Reynolds, I. J., & Hastings, T. G. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6374 · Cited by 115
Inhibition of Peroxynitrite‐Mediated Oxidation of Dopamine by Flavonoid and Phenolic Antioxidants and Their Structural Relationships
Kerry, N. L., & Rice-Evans, C. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730247.x · Cited by 113
VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease
Taylor, T. N., Caudle, W. M., & Miller, G. W. (2011) · Parkinson s Disease · doi:10.4061/2011/124165 · Cited by 113
“The monoamines, particularly DA and norepinephrine (NE) have the ability to spontaneously oxidize in the cytosol, potentially damaging cellular machinery [21].”
Background
Proteasomal activity in brain differs between species and brain regions and changes with age.
Zeng, B.-Y., Medhurst, A. D., Jackson, M., Rose, S., & Jenner, P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.008 · Cited by 113
5‐S‐Cysteinyl‐conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase‐3 activity in neurons
Spencer, J. P. E., Whiteman, M., Jenner, P. G., & Halliwell, B. B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00808.x · Cited by 113
Oxidative and non‐oxidative mechanisms of neuronal cell death and apoptosis by L ‐3,4‐dihydroxyphenylalanine ( L ‐DOPA) and dopamine
Pedrosa, R., & Soares-da-Silva, P. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704982 · Cited by 115
“On the other hand, toxic e ects of dopamine may result via either oxidative deamination by MAO or autoxidation (Graham, 1978; Michel & Hefti, 1990; Rosenberg, 1988).”
BackgroundResultInfluential
Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese
Galvani, P., Fumagalli, P., & Santagostino, A. (1995) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)90058-6 · Cited by 112
Methamphetamine‐induced dopaminergic neurotoxicity is regulated by quinone formation‐related molecules
Miyazaki, I., Asanuma, M., Diaz-Corrales, F. J. J., Fukuda, M., Kitaichi, K., Miyoshi, K., & Ogawa, N. (2006) · The FASEB Journal · doi:10.1096/fj.05-4996fje · Cited by 111
“However, excessive levels of cytosolic DA outside the vesicles in damaged DA neurons is thought to induce neurotoxicity through the generation of ROS and reactive DA quinones (15, 16).”
Background
Decreased brain dopamine cell numbers in human cocaine users
Little, K. Y., Ramssen, E., Welchko, R. M., Volberg, V., Roland, C. J., & Cassin, B. J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.034 · Cited by 113
“Dopamine is known to spontaneously oxidize both de novo, or via an enzyme-catalyzed reaction in vivo, to form reactive oxygen species which are damaging to cellular components such as lipids, proteins, and DNA (Graham, 1978).”
Background
Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder
Özdemir, E., Çetinkaya, S., Erşan, S., Kucukosman, S., & Erşan, E. E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.004 · Cited by 108
Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
Cadet, J. L., Jayanthi, S., McCoy, M. T., Beauvais, G., & Cai, N. S. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361496 · Cited by 114
“The manner by which DA exerts its toxic effects have been attributed, mainly, to the production of reactive quinones and other reactive species that are generated by oxidative DA metabolism [151-153].”
Background
Chemicals and Drugs Forming Reactive Quinone and Quinone Imine Metabolites
Klopčič, I., & Dolenc, M. S. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00213 · Cited by 112
Apoptosis: A Key in Neurodegenerative Disorders
Ekshyyan, O. Y., & Aw, T. Y. (2004) · Current Neurovascular Research · doi:10.2174/1567202043362018 · Cited by 110
Oxidative Modification of Peroxiredoxin Is Associated with Drug-induced Apoptotic Signaling in Experimental Models of Parkinson Disease
Lee, Y. M., Park, S. H., Shin, D.-I., Hwang, J.-Y., Park, B., Park, Y.-J., Lee, T. H., Chae, H. Z., Jin, B. K., Oh, T. H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800426200 · Cited by 109
l-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells
Stansley, B. J., & Yamamoto, B. K. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.010 · Cited by 112
“It is likely that dopa and synthesized dopamine can spontaneously oxidize to their quinones (Asanuma et al., 2003; Basma et al., 1995; Graham, 1978; Stokes et al., 1999) and produce damage to 5-HT neurons.”
Background
Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive Intermediate
Jinsmaa, Y., Florang, V. R., Rees, J. N., Anderson, D. G., Strack, S., & Doorn, J. A. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800405v · Cited by 106
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity
Zou, L., Jankovic, J. J., Rowe, D. B., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00062-4 · Cited by 105
Modulation of Antioxidant Defense Systems by the Environmental Pesticide Maneb in Dopaminergic Cells
Barlow, B. K., Lee, D. W., Cory‐Slechta, D. A., & Opanashuk, L. A. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.07.004 · Cited by 104
Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine
Shankaran, M., Yamamoto, B. K., & Gudelsky, G. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00728-1 · Cited by 105
Chronic L‐DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6‐OHDA or FeCl3 nigrostriatal lesions
Datla, K. P., Blunt, S. B., & Dexter, D. T. (2001) · Movement Disorders · doi:10.1002/mds.1091 · Cited by 103
Oberflächenmodifizierung von Wasseraufbereitungsmembranen
Miller, D. J., Dreyer, D. R., Bielawski, C. W., Paul, D. R., & Freeman, B. D. (2016) · Angewandte Chemie · doi:10.1002/ange.201601509 · Cited by 104
The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration
Mor, D. E., Daniels, M. J., & Ischiropoulos, H. (2019) · Movement Disorders · doi:10.1002/mds.27607 · Cited by 107
“Oxidation of dopamine generates electron-deficient quinones and reactive, partially reduced oxygen species.(6,30,31) Further oxidation and polymerization of dopamine leads to the formation of neuromelanin, an insoluble granular pigment thought to be protective in that it sequesters reactive dopamine derivatives.”
Background
Low levels of arsenite activates nuclear factor‐κB and activator protein‐1 in immortalized mesencephalic cells
Felix, K., Manna, S. K., WISE, K. C., Barr, J. L., & Ramesh, G. T. (2005) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20062 · Cited by 103
“Second, the catechol ring of DA can undergo oxidation to form DA quinine and ROS such as H2O2 and superoxide anion ( ) in a reaction that can occur either spontaneously in the presence of transition of metals or enzymatically [20,21].”
Background
Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults
Liu, F., Hindupur, J., Nguyen, J. L., Ruf, K. J., Zhu, J., Schieler, J. L., Bonham, C. C., Wood, K. V., Davisson, V. J., & Rochet, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.022 · Cited by 102
“Dopaminergic neurons of the substantia nigra contain relatively high basal levels of ROS resulting from dopamine metabolism and auto-oxidation [10].”
Background
Methylphenidate Exposure Induces Dopamine Neuron Loss and Activation of Microglia in the Basal Ganglia of Mice
Sadasivan, S., Pond, B. B., Pani, A. K., Qu, C., Jiao, Y., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033693 · Cited by 102
“The subsequent oxidation of 5-S-cysteinyl DA produces a number of neurotoxic compounds [17].”
Background
Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
Kokoshka, J. M., Vaughan, R. A., Hanson, G. R., & Fleckenstein, A. E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00741-9 · Cited by 102
Oxidation and Nitration of Catecholamines by Nitrogen Oxides Derived from Nitric Oxide
Daveu, C., Servy, C., Dendane, M., Marin, P., & Ducrocq, C. (1997) · Nitric Oxide · doi:10.1006/niox.1997.0123 · Cited by 101
Oxidative damage in substantia nigra and striatum of rats chronically exposed to ozone
Pereyra-Muñoz, N., Rugerio-Vargas, C., Angoa‐Pérez, M., Borgonio-Pérez, G., & Rivas-Arancibia, S. (2005) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2005.09.006 · Cited by 99
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson’s disease: relationship to clinical data
Ihara, Y., CHUDA, M., Kuroda, S., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00192-6 · Cited by 100
Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides
Fitsanakis, V. A., Amarnath, V., Moore, J. T., Montine, K. S., Zhang, J., & Montine, T. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01169-3 · Cited by 100
Multiple Antioxidants in the Prevention and Treatment of Parkinson’s Disease
Prasad, K. N., Cole, W. C., & Kumar, B. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718878 · Cited by 102
Genetics of iron regulation and the possible role of iron in Parkinson's disease
Rhodes, S. L., & Ritz, B. R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.001 · Cited by 103
Interaction of exercise and ethanol on antioxidant enzymes in brain regions of the rat
Somani, S. M., Husain, K. M., Diaz-Phillips, L., Lanzotti, D. J., Kareti, K. R., & Trammell, G. L. (1996) · Alcohol · doi:10.1016/s0741-8329(96)00075-4 · Cited by 99
Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine
Lee, M. K., Kang, S. J., Poncz, M., Song, K., & Park, K. S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.42 · Cited by 99
Peroxynitrite Inactivates the Human Dopamine Transporter by Modification of Cysteine 342: Potential Mechanism of Neurotoxicity in Dopamine Neurons
Park, S. U., Ferrer, J. V., Javitch, J. A., & Kuhn, D. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04399.2002 · Cited by 99
“Stable o-quinones were formed by oxidizing DA or N-acetyl-DA with one equivalent of NaIO4 immediately before addition to cells (Graham, 1978; Graham et al., 1978).”
Method
Environmental Chemistry and Chemical Ecology of “Green Tide” Seaweed Blooms
Alstyne, K. L. V., Nelson, T. A., & Ridgway, R. L. (2015) · Integrative and Comparative Biology · doi:10.1093/icb/icv035 · Cited by 101
Impaired iron homeostasis in Parkinson’s disease
Double, K. L., Gerlach, M., Youdim, M. B. H., & Riederer, P. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_3 · Cited by 101
Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine
Salvemini, D., & Cuzzocrea, S. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00005 · Cited by 96
“It has been known since the mid 1970s that superoxide interacts with catecholamines (these are, in fact, considered as antioxidants), converting them to adrenochromes (100, 101).”
Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: Implications for Parkinson’s disease and protection by polyphenols
Vauzour, D., Ravaioli, G. M., Vafeiadou, K., Rodriguez‐Mateos, A., Angeloni, C., & Spencer, J. P. E. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.011 · Cited by 96
Free radical mechanisms in schizophrenia and tardive dyskinesia
Cadet, J. L., & Kahler, L. A. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90001-9 · Cited by 97
Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides
Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M., & Sonnino, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741758.x · Cited by 95
Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner
Pham, C. L. L., Leong, S. L., Ali, F. E. A., Kenche, V. B., Hill, A. F., Gras, S. L., Barnham, K. J., & Cappai, R. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.007 · Cited by 99
Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity
Miyazaki, I., Asanuma, M., Kikkawa, Y., Takeshima, M., Murakami, S., Miyoshi, K., Sogawa, N., & Kita, T. (2010) · Glia · doi:10.1002/glia.21112 · Cited by 96
Neurotoxins and neurotoxic species implicated in neurodegeneration
Segura‐Aguilar, J., & Kostrzewa, R. M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033456 · Cited by 95
Antidepressant-like Effect of Tetrahydroisoquinoline Amines in the Animal Model of Depressive Disorder Induced by Repeated Administration of a Low Dose of Reserpine: Behavioral and Neurochemical Studies in the Rat
Antkiewicz‐Michaluk, L., Wąsik, A., Możdżeń, E., Romańska, I., & Michaluk, J. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9454-8 · Cited by 95
“The monoamines, particularly DA and NA have the ability to undergo spontaneous oxidation in the cytosol, which is potentially damaging to cellular structures (Graham 1978; Antkiewicz-Michaluk et al. 2006; Wąsik et al. 2009).”
Background
Levodopa: Effect on cell death and the natural history of Parkinson's disease
Olanow, C. W. (2014) · Movement Disorders · doi:10.1002/mds.26119 · Cited by 95
“In addition, both L-dopa and dopamine can undergo auto-oxidation to form potentially toxic semiquinones.(3,4) Indeed, in the SNc of patients with PD, iron levels, which promote oxidation, are increased,(5) GSH levels, which defend against oxidation, are reduced,(6) cysteinyldopa levels, which provide an index of autox…”
Background
Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia
Metzger, R. R., Haughey, H. M., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39008-1 · Cited by 94
Relationship of Possible Stress-Related Biochemical Markers to Oxidative/Antioxidative Status in Obsessive-Compulsive Disorder
Behl, A., Swami, G., Sircar, S., Bhatia, M. S., & Banerjee, B. (2010) · Neuropsychobiology · doi:10.1159/000306591 · Cited by 93
Reactive Dopamine Metabolites and Neurotoxicity
Hastings, T. G., Lewis, D. A., & Zigmond, M. J. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9480-9_13 · Cited by 94
Levodopa Is Toxic to Dopamine Neurons in an in Vitro but Not an in Vivo Model of Oxidative Stress
Mytilineou, C., Walker, R. H., JnoBaptiste, R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042267 · Cited by 94
“The addition of levodopa under these conditions could add to the pro-oxidant environment in the SNc by way of the formation of reactive oxygen species formed during the autoxidation or metabolism of levodopa and/or dopamine (Graham, 1978).”
Background
Peripheral Blood Markers of Oxidative Stress in Parkinson’s Disease
Younes, S., Frih-Ayed, M., Kerkeni, A., Bost, M., & Chazot, G. (2007) · European Neurology · doi:10.1159/000103641 · Cited by 92
Dopamine quinones interact with α-synuclein to form unstructured adducts
Bisaglia, M., Tosatto, L., Munari, F., Tessari, I., de Laureto, P. P., Mammi, S., & Bubacco, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.044 · Cited by 94
“The oxidation of DA leads to both toxic reactive oxygen species (ROS) and dopamine-quinones (DAQ) [4].”
Background
Inhibition of Vesicular Monoamine Transporter-2 Activity in α-Synuclein Stably Transfected SH-SY5Y Cells
Guo, J. T., Chen, A. Q., Kong, Q., Zhu, H., Ma, C. M., & Qin, C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9227-0 · Cited by 93
“Alternatively, it can be enzymatically deaminated by monoamine oxidase to produce toxic dopamine metabolites and ROS, such as superoxide and hydroxyl radicals (Graham 1978; Maker et al. 1981).”
6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism
Storch, A., Kaftan, A., Burkhardt, K., & Schwarz, J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050023 · Cited by 93
“At physiological pH 6-OHDA reacts with molecular oxygen to form quinones as well as radical oxygen species (Graham, 1978), including hydrogen peroxide (H2O2), anion superoxide O22 and hydroxyl radical (OH).”
Background
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease
Ahlskog, J. E., Uitti, R. J., Low, P. A., Tyce, G. M., Nickander, K. K., Petersen, R. C., & Kokmen, E. (1995) · Movement Disorders · doi:10.1002/mds.870100507 · Cited by 90
Pharmacological treatment of Parkinson’s disease
Münchau, A. M., & Bhatia, K. P. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.900.602 · Cited by 93
Dopamine-glutamate interactions in methamphetaminc-induced neurotoxicity
Marshall, J. F., O'Dell, S. J., & Weihmuller, F. B. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245234 · Cited by 93
“Oxidation products of DA include neurotoxins such as 6-hydroxydopamine (Seiden and Vosmer, 1984), quinones of dopamine (Graham, 1978; Rosengren etal., 1985; Fornstedt etal., 1990), or oxygen radicals (Cohen, 1990).”
Background
Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain
Bilska‐Wilkosz, A., Dubiel, M., ewicz, M. S. O.-J., Lorenc‐Koci, E., & Włodek, L. B. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.002 · Cited by 91
Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease?
Ziv, I., Zilkha‐Falb, R., Offen, D., et al. (1997) · Movement Disorders · doi:10.1002/mds.870120105 · Cited by 91
Isofurans, but not F2‐isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease
Fessel, J. P., Hulette, C., Powell, S. Z.-E., Roberts, L. J., & Zhang, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01709.x · Cited by 90
Autoxidation of dopamine: A comparison of luminescent and spectrophotometric detection in basic solutions
Klegeris, A., Korkina, L. G., & Greenfield, S. A. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00141-6 · Cited by 90
Dopamine Inactivates Tryptophan Hydroxylase and Forms a Redox-Cycling Quinoprotein: Possible Endogenous Toxin to Serotonin Neurons
Kuhn, D. M., & Arthur, R. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07111.1998 · Cited by 90
“DA was also converted enzymatically to the aminochrome by tyrosinase, and finally, N-acetyl-DA was oxidized by NaIO 4 to the more stable o-quinone (Graham, 1978; Graham et al., 1978).”
BackgroundMethodInfluential
Manganese Homeostasis and Transport
Roth, J. A., Ponzoni, S., & Aschner, M. (2012) · Metal ions in life sciences · doi:10.1007/978-94-007-5561-1_6 · Cited by 94
Oxidative stress in Parkinson's disease
Schapira, A. H. V. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01022.x · Cited by 90
Drug treatment of Parkinson’s disease
Drukarch, B., & Muiswinkel, F. L. V. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00340-8 · Cited by 89
Dopamine–melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease
Offen, D. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00150-7 · Cited by 90
Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer’s Disease
Nam, E., Derrick, J. S., Lee, S., Kang, J., Han, J., Lee, S. J. C., Chung, S. W., & Lim, M. H. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00122 · Cited by 89
Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration
Zeevalk, G. D., Bernard, L. P., Song, C., Gluck, M. J., & Ehrhart, J. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1117 · Cited by 89
“Catalase provides a secondary source of H O removal only when glutathione levels are severely depleted (71).”
The Roles of Dopamine Oxidative Stress and Dopamine Receptor Signaling in Aging and Age-Related Neurodegeneration
Luo, Y., & Roth, G. S. (2000) · Antioxidants and Redox Signaling · doi:10.1089/15230860050192224 · Cited by 87
“DA can oxidize spontaneously in vitro or through an enzyme-catalyzed reaction in vivo to form ROS and quinones (Cohen and Heikkila, 1974; Graham, 1978; Hastings, 1995).”
Decreases in dopamine concentrations in adult, non-human primate brain persist following removal from polychlorinated biphenyls
Seegal, R. F., Bush, B., & Brosch, K. O. (1994) · Toxicology · doi:10.1016/0300-483x(94)90054-x · Cited by 87
Reduction of Brain Glutathione by l ‐Buthionine Sulfoximine Potentiates the Dopamine‐Depleting Action of 6‐Hydroxydopamine in Rat Striatum
Pileblad, E., Magnusson, T., & Fornstedt, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb02550.x · Cited by 87
Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by l-BSO and apoptosis
Stokes, A. H., Lewis, D. Y., Lash, L. H., Jerome, W. G., Grant, K. W., Aschner, M., & Vrana, K. E. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02329-x · Cited by 85
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 87
Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats
Alirezaei, M., Khoshdel, Z., Dezfoulian, O., Rashidipour, M., & Taghadosi, V. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0360-0 · Cited by 84
Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: Implications for mitochondrial dysfunction in Parkinson disease
Bisaglia, M., Soriano, M. E., Arduini, I., Mammi, S., & Bubacco, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.006 · Cited by 86
“As previously reported [7], during the Ty-mediated oxidation of DA at physiological pH and 25 °C only AC is detectable in the optical spectra with no evidence for the presence of DQ.”
BackgroundInfluential
Neurotoxicity of MDMA: Neurochemical Effects
SCHMID, C. J., & Kehne, J. H. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16917.x · Cited by 84
Interaction Between Hyperthermia and Oxygen Radical Formation in the 5-Hydroxytryptaminergic Response to a Single Methamphetamine Administration
Fleckenstein, A. E., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37016-8 · Cited by 84
“…prevents the acute METHinduced decrease in TPH activity (Schmidt et al., 1985); and 2) dopamine may have oxidative consequences by causing formation of hydrogen peroxide, superoxide, dopamine quinones (Graham, 1978; Baez et al., 1995) or the neurotoxin 6-hydroxydopamine (Seiden and Vosmer, 1984).”
Neurotoxicity of Endogenous Cysteinylcatechols
Montine, T. J., Picklo, M. J., Amarnath, K., et al. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6662 · Cited by 83
Self-citation
Morphology, density and distribution of tyrosine hydroxylase-like immunoreactive cells in the retina of mice
Versaux‐Botteri, C., Nguyen‐Legros, J., Vigny, A., et al. (1984) · Brain Research · doi:10.1016/0006-8993(84)90423-2 · Cited by 82
Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes
Morel, P., Tallineau, C., Pontcharraud, R., Piriou, A., & Huguet, F. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00062-x · Cited by 82
Dopamine‐dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease
Choi, H. J., Kim, S. W., Lee, S. Y., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01808.x · Cited by 81
Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC 12 cells: relevance to the pathogenesis of Parkinson's disease
Goldstein, D. S., Sullivan, P., Cooney, A. M., Jinsmaa, Y., Sullivan, R., Gross, D., Holmes, C. S., Kopin, I. J., & Sharabi, Y. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07924.x · Cited by 78
Lipid Peroxidation Products Inhibit Dopamine Catabolism Yielding Aberrant Levels of a Reactive Intermediate
Rees, J., Florang, V. R., Anderson, D. G., & Doorn, J. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700248y · Cited by 86
Free radical production induced by methamphetamine in rat striatal synaptosomes
Pubill, D., Chipana, C., Camins, A., Pallàs, M., Camarasa, J., & Escubedo, E. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.08.008 · Cited by 80
Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites
Hastings, T. G., & Zigmond, M. J. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_11 · Cited by 81
Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
Post, M. R., Lieberman, O. J., & Mosharov, E. V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00161 · Cited by 82
“Spontaneous DA oxidation at neutral pH of the cytosol yields DA-o-quinone and dopaminochrome (Graham, 1978; Sulzer and Zecca, 2000), which can then react with free cysteine and exposed cysteine residues of proteins and glutathione producing 5-Scystenyl-DA.”
Background
Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra
McCormack, A. L., Mak, S. K., & Monte, D. A. D. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.50 · Cited by 80
“A pro-oxidant environment characterizes dopaminergic neurons and is reflected by their accumulation of neuromelanin, a product of dopamine oxidative metabolism.(24)”
Background
Oxidative stress and Parkinson's disease
Jenner, P. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83024-7 · Cited by 79
The Nithsdale Schizophrenia Surveys. XIV: Plasma Lipid Peroxide and Serum Vitamin E Levels in Patients with and Without Tardive Dyskinesia, and in Normal Subjects
McCreadie, R. G., MacDonald, E., Wiles, D. H., Campbell, G. R., & Paterson, J. R. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.5.610 · Cited by 78
“First,blockade of post-synapticneuronsby the antipsychoticdrug increasestheproductionandmetabolismof dopamine, whichmayleadto increasedformationof dopamine quinones (Graham, 1978) as well as hydrogen peroxide (Cohen, 1984),both of which cangenerate free radicals.”
Background
Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry
Lim, K., & Zhang, C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00033 · Cited by 82
“For SN dopaminergic neurons, the vulnerability toward oxidative stress is further enhanced by the abundance of redox-active iron in this region of the brain, as well as by the presence of DA, whose oxidation products are potentially cytotoxic (Graham, 1978).”
Background
Exposure, epidemiology, and mechanism of the environmental toxicant manganese
Chen, P., Culbreth, M. E., & Aschner, M. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-6687-0 · Cited by 79
“In dopaminergic (DAergic) neurons, Mn can catalyze autoxidation of dopamine (DA), producing DA-o-quinone, ROS, and hydrogen peroxide (H2O2) (Donaldson et al. 1982; GRAHAM 1978; Reaney and Smith 2005).”
Background
Tyrosinase-catalyzed binding of 3,4-dihydroxyphenylalanine with proteins through the sulfhydryl group
Kato, T., Ito, S., & Fujita, K. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90034-6 · Cited by 79
6-Hydroxydopamine: a far from simple neurotoxin
Varešlija, D., Tipton, K. F., Davey, G. P., & McDonald, A. G. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-019-02133-6 · Cited by 80
“The high reduction potential of 6-OHDA (+ 154 mV at pH 6.8; Graham 1978) is sufficient for releasing iron in its ferrous Fe(II) from the iron-storage protein ferritin (Gerlach et al.”
BackgroundInfluential
Lepeophtheirus salmonis: characterization of prostaglandin E2 in secretory products of the salmon louse by RP-HPLC and mass spectrometry
Fast, M. D., Ross, N. W., Craft, C., et al. (2004) · Experimental Parasitology · doi:10.1016/j.exppara.2004.04.001 · Cited by 78
Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
Duce, J. A., Wong, B. X. W., Durham, H., Devedjian, J.-C., Smith, D. P., & Devos, D. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0186-8 · Cited by 81
“Alternatively, DA can be spontaneously oxidised in the presence of oxygen to yield DA-o-quinone, H2O2 and superoxide [11].”
Dopamine and Iron Induce Apoptosis in PC12 Cells
Velez‐Pardo, C., Jiménez-Del-Río, M., Verschueren, H., Ebinger, G., & Vauquelin, G. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00287.x · Cited by 77
DNA damage in rats after treatment with methylphenidate
Andreazza, A. C., Frey, B. N., Valvassori, S. S., Zanotto, C., Gomes, K. M., Comim, C. M., Cassini, C., Stertz, L., Ribeiro, L. C., Quevedo, J., et al. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.012 · Cited by 76
α-Synuclein and Dopamine Metabolism
Yu, S., Uéda, K., & Chan, P. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:243 · Cited by 77
“DA can also undergo spontaneous autoxidation, at normal intracellular pH and in the presence of molecular oxygen, into toxic and reactive DA quinones, superoxide free radicals, and hydrogen peroxide (30).”

Authors: GRAHAM, D. G.
Affiliations: Duke Medical Center (US)
Corresponding author: GRAHAM, DOYLE G.
Venue: Molecular Pharmacology
Publisher: Elsevier BV
Published: 1978-07
Volume: 14
Issue: 4
Pages: 633-643
ISSN: 0026-895X (ISSN-L)
DOI: 10.1016/s0026-895x(25)13535-9
OpenAlex: W2211987820
Cited by: 1,126
References: 0
Citations by year: 2026: 11 · 2025: 12 · 2024: 6 · 2023: 11 · 2022: 13 · 2021: 20 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 30 · 2016: 26 · 2015: 29 · 2014: 26 · 2013: 26 · 2012: 49
FWCI: 1.86
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Molecular Pharmacology (publishedVersion)
PubMed (publishedVersion)
PubMed
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords: catecholamines, autoxidation, periodate oxidation, 6-hydroxydopamine, dopamine, norepinephrine, epinephrine, aminochrome, adrenochrome, o-quinones, p-quinones, cyclization, tautomerism, neuromelanin
MeSH terms: Catecholamines, Dopamine, Epinephrine, Hydroxydopamines, Melanins, Norepinephrine, Oxidation-Reduction, Quinones, Monophenol Monooxygenase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks